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Comprehensive analysis of blood cells and
plasma identifies tissue-specific miRNAs as
potential novel circulating biomarkers in
cattle
Jason Ioannidis and F. Xavier Donadeu*
Abstract
Background: The potential of circulating miRNAs as biomarkers of tissue function, both in health and disease, has
been extensively demonstrated in humans. In addition, circulating miRNA biomarkers offer significant potential towards
improving the productivity of livestock species, however, such potential has been hampered by the absence
of information on the nature and source of circulating miRNA populations in these species. In addition, many
miRNAs originally proposed as robust biomarkers of a particular tissue or disease in humans have been
later shown not to be tissue specific and thus to actually have limited biomarker utility. In this study, we
comprehensively analysed miRNA profiles in plasma and cell fractions of blood from cattle with the aim to
identify tissue-derived miRNAs which may be useful as biomarkers of tissue function in this important food
animal species.
Results: Using small RNA sequencing, we identified 92 miRNAs with significantly higher expression in plasma
compared to paired blood cell samples (n = 4 cows). Differences in miRNA levels between plasma and cell
fractions were validated for eight out of 10 miRNAs using RT-qPCR (n = 10 cows). Among miRNAs found to
be enriched in plasma, we confirmed miR-122 (liver), miR-133a (muscle) and miR-215 (intestine) to be tissue-
enriched, as reported for other species. Profiling of additional miRNAs across different tissues identified the
human homologue, miR-802, as highly enriched specifically in liver.
Conclusions: These results provide novel information on the source of bovine circulating miRNAs and could
significantly facilitate the identification of production-relevant tissue biomarkers in livestock. In particular, miR-
802, a circulating miRNA not previously identified in cattle, can reportedly regulate insulin sensitivity and lipid
metabolism, and thus could potentially provide a specific biomarker of liver function, a key parameter in the
context of post-partum negative energy balance in dairy cows.
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Background
MicroRNAs (miRNAs) are short, non-coding RNA mole-
cules which are primarily involved in the post-
transcriptional fine-tuning of gene expression [1]. Since the
discovery of lin-4 in Caenorhabditis elegans in 1993, thou-
sands of miRNAs have been identified and characterised [2,
3]. It is now known that miRNAs are involved in the regu-
lation of virtually all developmental processes, from the
embryo to the adult [4–7], as well as in disease [8].
The discovery of cancer-associated miRNAs together
with the detection of miRNAs in bio fluids [9] sparked a
wave of research into the potential use of extracellular
miRNAs as biomarkers of disease. A miRNA biomarker
can be defined as a miRNA that is specifically produced
or enriched in a given tissue, the circulating levels of
which may reflect pathological or physiological changes
in said tissue. In recent years, the value of circulating
miRNAs as diagnostic biomarkers has been shown in re-
lation to cancer (e.g. miR-21, miR-20, miR-221 [10, 11]),
cardiovascular disease (miR-1, miR-133a [12]), liver dis-
ease (miR-122 [13]) and diabetes (miR-375 and miR-34
[14]), among many other human pathologies and physio-
logical processes including pregnancy [15].
However, recent work has urged caution in interpret-
ing the results of miRNA biomarker studies [16, 17].
Specifically, a large number of miRNAs initially pro-
posed as cancer biomarkers were later shown not to be
tissue-specific, contrary to what would be expected from
a robust tissue biomarker. Many of those miRNAs were
found to be present in blood cells, which are a major
contributor of miRNAs in circulation [16], and their cir-
culating levels were shown to be affected by changes in
blood cell numbers. In addition, a review of non-cancer,
disease-related miRNA biomarkers found that the ma-
jority of proposed biomarkers were not tissue-specific
and, moreover, were not expressed in the disease-
relevant tissues [18]. These reports highlight the need
for further studies to identify the source of proposed
miRNA biomarkers and determine their enrichment in
the tissue(s) of interest.
The potential of miRNA biomarkers in food-
producing species has also been reported, although in a
much smaller number of studies than in humans. The
identification of biomarkers associated with specific pro-
duction traits and disease conditions in cattle would be
of significant agricultural importance. A handful of stud-
ies have already linked circulating miRNA profiles with
pregnancy and the oestrous cycle [19, 20], infection [21,
22] and grazing [23] in cattle, as well as with bacterial
disease and feed deprivation in other domestic species
[24]. However, the source and tissue-specificity of circu-
lating miRNA populations in these species have not been
determined which, in view of the above, limits the prac-
tical significance of those results.
To address these limitations and facilitate the discov-
ery in cattle of circulating bona-fide miRNA biomarkers,
we sought to profile miRNA populations in different
blood fractions in order to distinguish miRNAs
expressed in blood cells from those expressed in other
body tissues which could provide novel specific bio-
markers. Using next-generation sequencing, we provide
a list of potential tissue-enriched miRNAs in circulation
including miR-802, a previously uncharacterised bovine
liver-specific miRNA which may prove useful as a
disease biomarker in high-producing cows.
Methods
Sample collection
Blood samples were collected in EDTA-coated tubes
(Becton Dickinson, USA) from the jugular vein of six
non-pregnant Holstein-Friesian cross cows, aged be-
tween 20 and 25 months and held at Langhill Farm
(University of Edinburgh), with the relevant ethics ap-
proval (see Declarations). From each blood sample, a
plasma fraction was obtained using a two-step centrifu-
gation protocol [19] to separate blood cells [25] followed
by filtration through 0.2 μm syringe filters (Sartorius,
Germany) to ensure the removal of any residual cellular
debris. Subsequently, a cell fraction was obtained from a
different volume (100 μL) of the same blood sample by
centrifugation at 1900 x g for 10 min at 4 °C. The result-
ing supernatant was discarded and the cell pellet
(consisting of red blood cell and buffy coat fractions)
was re-suspended in RNase-free water up to a volume of
250 μL. The blood cell solution was immediately used
for RNA extraction as described below.
Bovine tissue samples including brain, heart, intestine,
kidney (cortex and medulla combined), liver, lung, skel-
etal muscle, ovary, placenta (placentome and interpla-
centome combined), skin, spleen and uterus were
collected from a local abattoir in ice-cold PBS. Upon ar-
rival in the laboratory tissues were dissected, labelled,
weighed and snap-frozen in dry ice. All samples were
stored at − 80 °C until further use.
RNA extraction
All plasma, cell and tissue samples were extracted using
TRIzol LS (Life Technologies, USA), as described [19],
following the manufacturer’s protocol. Blood cells
(250 μL) were homogenised using three volumes of TRI-
zol LS. Other tissues (each 50 mg) were thawed in 1 mL
of TRIzol LS and homogenised with Lysing Matrix D
(MP Biomedicals, UK) and a FastPrep FP120 Tissue Dis-
ruptor (Thermo Electron, USA). Before extraction, sam-
ples of plasma (700 μL) and blood cells (250 μL) were
spiked with 3.5 μL of exogenous cel-miR-39-3p (5.6 ×
108 copies per sample, Qiagen), and glycogen (40 μg;
Sigma-Aldrich, USA) was added in the presence of 1/10
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per volume of 5 M ammonium acetate salt (Sigma-Al-
drich), as recommended by the manufacturer, to facili-
tate RNA precipitation. RNA pellets from plasma, blood
cells and other tissues were re-suspended, respectively,
in 20, 10 and 40 μL of RNase-free water (Qiagen) and
used immediately or frozen at − 80 °C until use. RNA
content and quality from cell and tissue samples were
determined using the Nanodrop ND-1000 Spectropho-
tometer (Thermo Fisher Scientific, USA).
Small RNA sequencing
Small RNA libraries were prepared from four matched
samples of blood plasma and cells using the TruSeq
Small RNA Library Preparation Kit (Illumina, USA) and
were submitted to 36-base single-end sequencing on the
HiSeq 2000 Sequencing System (Illumina). Small RNA
libraries were prepared using 5 μL of RNA extract. Raw
sequencing data, available on the GEO database (Acces-
sion GSE84871 [26]), were analysed using sRNAbench 1.
0 [27, 28]. Briefly, the software was run in genome mode
using default settings, with the bovine genome (bosTau4)
and miRBase 21 as reference (accessed on 30 April 2015
[29, 30]) in order to identify bovine (bta) miRNAs and
human (hsa) miRNA homologues. Human homologues
not previously described in bovine were identified by
taking reads that aligned to the bovine genome but did
not match with known bovine sequences in miRBase
and aligning them to human sequences in miRBase.
Throughout the manuscript, these miRNAs are indicated
with the suffix hsa-. A single nucleotide mismatch was
allowed when mapping reads to known miRNA se-
quences. Before mapping, reads without sequencing
adaptor or with undetermined bases, and reads below 15
nucleotides in length (after adaptor removal) were re-
moved and not used for subsequent analyses. For add-
itional details about the integrated analysis steps in
sRNAbench please refer to the software manual (http://
bioinfo2.ugr.es:8080/ceUGR/srnabench/).
Normalised reads (reads per million mapped, RPMM)
obtained from sRNAbench were filtered before being
passed to edgeR 3.10.2 for differential expression ana-
lysis in R language 3.2.1 [31, 32]. Prior to analysis, miR-
NAs which were detected with less than 25 RPMM in
more than two samples of either plasma or cells were
excluded in order to increase confidence in subsequent
analysis and reduce technical noise. Differential expres-
sion analysis was performed using edgeR’s paired mode
on 212 miRNAs (Additional file 1) using GLMfit, as de-
scribed in [33]. The statistical significance was set to
false discovery rate (FDR) < 0.05.
Identification of potential novel biomarkers in cattle
Potential novel tissue biomarkers were identified using
the list of miRNAs which were enriched in plasma
(Additional file 1). MiRNAs that were either registered
for bovine but not human, or that were human homo-
logues not previously identified in cow were selected. To
do this, Ensembl genome browser 85 (www.ensembl.org,
[34]), NCBI (www.ncbi.nlm.nih.gov) and miRBase 21
(www.mirbase.org [35]) were used to identify miRNAs
annotated in cow and human, and to determine their
conservation between the two species. BLAST was also
used (accessed via Ensembl at www.ensembl.org/Multi/
Tools/Blast?db=core, [36]) with default settings to iden-
tify the genomic location of selected miRNAs.
RT-qPCR
MiRNA levels were quantified in matched blood plasma
and cell samples. For plasma samples, 2 μL RNA were
reverse-transcribed in a 10 μL reaction using the miS-
cript II RT Kit (Qiagen) in a Whatman-Biometra Ther-
mocycler (Biometra, USA). For blood cell and other
tissue samples, 500 ng of RNA were used in each 10 μL
reaction. The cDNA template was diluted 40-fold and
added to 10 μL qPCR reactions which were prepared in
96-well format using the miScript SYBR Green PCR Kit
(Qiagen). Template amplification was carried out in an
Agilent MX3000P qPCR system (Agilent Technologies,
USA). Raw fluorescence data were collected using
MxPro software (Agilent Technologies). The amplifica-
tion efficiency ranged between 84.5% and 117.4%, with
R2 > 0.86. Expression levels were determined relative to a
freshly-made standard curve and data were analysed
using Microsoft Excel (Microsoft Corporation, USA). Ex-
pression levels were normalised to the mean expression
of spiked-in cel-miR-39-3p for plasma and blood cells.
For other tissues, expression data were normalised to
RnU6–2.
Statistical analyses were carried out using GraphPad
Prism 7 (GraphPad Software, USA). Differences in
miRNA expression between blood plasma and cell sam-
ples were assessed using paired t-tests. In all cases, nor-
mality was tested using the Shapiro-Wilk normality test,
outliers were tested with the ROUT test, and data were
log2(x + 1) transformed to meet the tests’ normality cri-
teria. Statistical significance was set to P < 0.05.
Results and discussion
Small RNA sequencing of different blood fractions
To determine the relative abundance of miRNAs in dif-
ferent blood compartments, we sequenced miRNAs in
paired blood plasma and cell fractions from four cows.
Analysis of read length distributions showed a peak at
20–23 nucleotides (characteristic of mature miRNAs) in
blood cells and, although of lesser magnitude, in plasma
(Fig. .1a). Unlike blood cells, plasma samples displayed
an additional peak at 7–9 nucleotides. We attribute the
higher proportion of short RNA fragments in plasma
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relative to cell samples to 1) the higher RNase content
in plasma [9] resulting in higher levels of RNA degrad-
ation and 2) the relatively lower abundance of RNAs in
plasma resulting in libraries with a higher proportion of
adapter/adapter complexes. The difficulty associated
with visualising low abundance cDNA bands on a gel
during preparation of the plasma library likely resulted
in many of the shorter sequences being included for
sequencing.
Averaged for both plasma and cells, we obtained 14.9
million raw reads per sample (Table 1). After removing
reads with low quality (reads without adapter, short
reads and reads with multiple undetermined base calls),
we mapped on average 5.9 million and 13.3 million reads
to the bovine genome (see Methods) which correspond
to 38.1% and 94.3% of the total reads for plasma and
cells, respectively (Table 1, Fig. .1b). On average, plasma
generated 2.7 million miRNA reads compared to 12.3
million reads for cells, the majority of which were, in
both cases, bovine miRNAs (Table 1, Fig. .1b). After ap-
plying a detection threshold of 10 reads per sample, we
Fig.1 Results of small RNA sequencing analysis. a Length distribution (mean ± SEM) of reads (before filtering out short reads) from paired
plasma and cell samples of blood from four animals. b Bar plot showing the relative distribution of sequencing reads corresponding to miRNAs,
non-miRNAs and excluded reads in individual blood plasma (PL) and cell (BC) samples
Table 1 Distribution of sequencing reads (RPMM) from paired
blood plasma and cell samples (n = 4 cows)
Plasma Cells
Raw reads 15,553,150 14,194,750
Reads without adapter (excluded) 127,738 237,726
Short reads (excluded) 9,469,537 672,891
Low quality reads (excluded) 20,587 25,532
Mapped reads 5,935,288 13,258,602
Total miRNA reads 2,688,243 12,309,110
of which bovine 2,683,651 12,307,733
of which human 4592 1377
Detected miRNAs (> 10 reads) 315 305
of which bovine 298 289
of which human 17 16
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detected up to 315 unique miRNAs in plasma samples
and 305 in cell samples, of which only 17 and 16, re-
spectively, were human homologues (Table 1).
Differentially expressed miRNAs in blood plasma and cells
There was incomplete overlap between the lists of most
abundant miRNAs in plasma and cells, with only 5 of
the 15 most abundant miRNAs being common to the
two lists, i.e. miR-486, miR-142-5p, miR-191, miR-92a
and miR-30e-5p (Table 2).
Principal component analysis (PCA) of a total of
212 miRNAs that were detected with ≥25 RPMM in
more than two samples of either plasma or cells (see
Methods, Additional file 1) produced well-separated
plasma and cell populations, with a single component
(PC1) accounting for 83.9% of the variation across
samples (Fig. 2a). Moreover, 169 miRNAs were differ-
entially expressed between plasma and cells (FDR < 0.
05, Fig. 2b, Additional file 1), with as many as 131
miRNAs changing by more than two-fold. Of these,
92 miRNAs were enriched in plasma and 39 miRNAs
were enriched in blood cells (Table 3, Fig. 3 and Add-
itional file 1). Among miRNAs enriched in plasma
were several known to be expressed exclusively or
predominantly in specific tissues in humans including
miR-122 (liver), miR-133a (muscle), miR-127 (adrenal
gland), miR-141 (adrenal gland and reproductive sys-
tem) and miR-182 (thymus) [37, 38]. Moreover, miR-
NAs enriched in the bovine blood cell fraction
included many previously reported to be blood cell-
derived in humans, such as miR-144, miR-451, let-7f,
miR-26a, miR-15b, miR-20a, miR-16a, miR-16b and
miR-486 [18, 25, 37, 39–41].
Validation of sequencing results using RT-qPCR
We used RT-qPCR to validate differences involving a
total of 10 miRNAs (indicated in bold in Additional
file 1) using samples from a total of six animals (in-
cluding the four animals used for sequencing). Levels
of one of the miRNAs selected for validation (miR-
429) could not be accurately quantified in most
samples because of its low abundance. For the
remaining nine miRNAs (Fig. 4a) we confirmed differ-
ences (P < 0.05) in the levels of all but miR-375 be-
tween plasma and cell samples (Fig. 4b). We then
sought to validate the results for these eight miRNAs
(miR-122, miR-215, miR-133a, miR-144, miR-451, and
miR-6119-5p, miR-26a and let-7f ) using samples from
an independent group of animals (four Holstein-
Friesian cross cows, aged between 24 and 48 months,
in late pregnancy or post-partum) and we confirmed
differences in plasma and cell levels of seven miRNAs
(Additional file 2); levels of miR-133a were very low
(Ct 34–37) in the original group of animals and were
undetectable in this second group.
MiRNA profiling across bovine tissues
To identify novel tissue-specific miRNAs in cattle we in-
vestigated the distribution across 14 different body tis-
sues of several miRNAs which expression we had found
to be enriched in plasma (Additional file 1). We first
profiled three miRNAs, miR-122, miR-133a and miR-
215, known to be tissue-specific in humans [37, 38]. Ac-
cordingly, the three miRNAs (Fig. 5a) were expressed
predominantly in liver (miR-122, 88-fold higher than in
any other tissue), muscle/heart (miR-133, 254-fold
higher) and intestine (miR-215, 150-fold higher).
We then sought to identify novel tissue biomarkers.
First, from the list of miRNAs enriched in plasma (Add-
itional file 1), we looked for miRNAs that were either
registered for bovine but not human, or that were hu-
man homologues not previously identified in cow, as de-
scribed in the Materials and Methods. These analyses
revealed 10 miRNAs which either were present in bovine
but not in human (miR-1388-5p, miR-1388-3p, miR-
2376, miR-2285 t, miR-3431 and miR-6529a, Fig. 5b) or
were homologues of human miRNAs not identified pre-
viously in cow (miR-210-3p, miR-802, miR-4532 and
miR-4792, Fig. 5c).
RT-qPCR analyses showed that the majority of these
miRNAs were expressed in most of the tissues profiled,
i.e., they were not enriched in any particular tissue and
therefore do not provide potential biomarkers of tissue
function (Fig. 5b-c). Surprisingly, miR-1388-3p, miR-
2376 and miR-6529 showed high expression in blood
Table 2 Most abundant miRNAs in paired blood plasma and
cell samples (n = 4 cows) obtained by sequencing
Plasma Cells
MiRNA RPMM MiRNA RPMM
miR-22-3p 126,167 miR-486 324,749
miR-486 125,775 miR-451 187,081
miR-192 101,853 miR-101 90,473
miR-27b 43,371 miR-92a 44,722
miR-142-5p 39,727 miR-16b 33,980
miR-423-5p 35,409 miR-26a 32,849
miR-191 32,448 miR-25 30,232
miR-215 28,947 miR-142-5p 20,925
miR-21-5p 25,484 miR-191 19,656
miR-10b 25,277 miR-181a 15,753
miR-92a 23,608 miR-186 14,137
miR-103 22,481 let-7f 12,830
miR-140 19,501 miR-30e-5p 11,955
miR-148a 19,108 miR-144 9847
miR-30e-5p 19,058 miR-93 9760
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cells despite having been identified as plasma-enriched
using sequencing. A possible explanation for this result
is that, despite blood cells having the highest levels of
these miRNAs, the combined contribution from all other
tissues to plasma levels is still greater in comparison.
Interestingly, in addition to blood cells, all three miR-
NAs were relatively abundant in spleen (Fig. 5b), which
suggests an involvement in hematopoietic regulation.
However, since no functional data is available for any of
the three miRNAs in any species, further study will be
needed to confirm this.
Among the remaining miRNAs, miR-3431 was dis-
tinctly high in lung followed by placenta and uterus.
This is a ruminant-specific miRNA which has been
reported to be expressed in adipose and reproductive tis-
sues of cattle [42, 43], although no information is avail-
able on its potential functions. Whether miR-3431 could
provide a useful circulating biomarker of lung function
in cows should be investigated in future studies.
Of note, the human homologue of miR-802 was dis-
tinctly enriched in liver, where its expression was 87-fold
higher than the mean expression across all tissues, and
5.2-fold higher than in intestine, the tissue with the sec-
ond highest mean expression levels (Fig. 5c). Using
BLAT (UMD3.1, accessed 27/07/16) we mapped the
mature miR-802 sequence to bovine chromosome 1
Fig. 2 Small-RNA sequencing results. a PCA plot showing the first two principle components using transformed normalised data. b Volcano
plot of fold-change (miRNA levels in blood plasma relative to cells) versus statistical significance (P-values), using transformed normalised data.
MiRNAs with fold-change > 2 and FDR < 0.05 are highlighted in red. Grey dotted lines indicate two-fold difference thresholds. The orange dotted
line indicates P = 0.05. Paired blood plasma and cell samples from four animals were analysed
Table 3 The 15 most enriched miRNAs in blood plasma and cell samples (n = 4 cows) obtained by sequencing
Plasma-enriched miRNAs Fold-change Plasma/Cells Blood cell enriched miRNAs Fold-change Cells/Plasma
miR-429 Expressed exclusively in plasma miR-107 54.19
miR-200a 6503.71 miR-6119-5p 28.01
miR-205 5220.54 miR-185 27.94
miR-215 2168.64 miR-144 16.56
miR-455-5p 1707.35 miR-451 10.31
miR-100 1498.54 miR-331-3p 8.55
miR-199a-5p 1359.19 miR-454 7.92
miR-10b 1339.56 miR-339a 7.61
hsa-miR-802 1092.70 let-7f 7.16
miR-199c 1041.52 miR-23b-3p 6.53
miR-214 931.10 miR-26a 6.08
miR-141 699.78 miR-98 5.72
miR-455-3p 635.12 let-7a-5p 5.60
miR-122 493.42 miR-101 5.39
miR-126-5p 412.95 miR-197 5.36
FDR < 0.05 for all miRNAs
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(chr1: 149720302–149,720,392 [+]). Indeed, this location
in the bovine genome has been annotated as a novel
miRNA with a secondary structure that matches miR-
802. Although not previously reported in cow, data in
humans and mice have shown miR-802 to be a key a
regulator of liver function. Specifically, hepatic levels of
miR-802 were elevated in obese individuals, contributing
to insulin insensitivity, glucose intolerance and increased
hepatic gluconeogenesis by downregulation of HNF1B
[44]. Interestingly, serum miR-802 levels were reportedly
increased in type 2 diabetes patients providing a poten-
tial circulating biomarker for this disease [45]. Another
study identified miR-802 as a target of constitutive
androstane receptor (CAR) signalling, which is involved
in the regulation of xenobiotic detoxification, lipid
homeostasis and energy metabolism [46]. Furthermore,
circulating miR-802 has been proposed as a biomarker
of drug-induced liver damage in rats, with an observed
increase in miRNA levels in response to tissue damage
being comparable to that of the liver-enriched miR-122
[47, 48]. Overall, these results highlight the importance
of miR-802 in the regulation of glucose and lipid metab-
olism as well as xenobiotic responses in the liver.
In dairy cattle, negative energy balance (NEB) often
occurs during the post-partum period as a consequence
of the high energy requirements for lactation. The liver
has a central role in counteracting NEB. Liver dysfunc-
tion often ensues during the post-partum period, par-
ticularly in high-producing cows, in association with
metabolic dysfunction and low fertility, constituting a
major problem in modern dairy herds [49]. Changes in
the expression of some miRNAs in liver have been
shown in association with NEB in cattle [49]. In this
context, future studies should investigate whether miR-
802, perhaps in combination with liver-enriched miR-
122, may provide a potential biomarker of negative en-
ergy balance in dairy cows.
Conclusions
Using next-generation sequencing, we compared for
the first time miRNA levels in paired plasma and cell
fractions of bovine blood and identified a total of 131
miRNAs that were differentially expressed (greater
than two-fold) between the two fractions. Of those,
92 miRNAs were expressed at higher levels in plasma
than in cells. Expression profiling of selected plasma-
Fig. 3 Heat map of top miRNAs differentially expressed in paired samples of blood plasma (PL) and cells (BC). Each row in the heat map represents a
miRNA and each column represents a sample. The colour scale illustrates the relative expression level of miRNAs. FDR < 0.05, n = 4 cows
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Fig. 4 Validation of sequencing results. a Comparison of the fold-changes in miRNA levels in blood plasma relative to cells obtained using
sequencing and RT-qPCR. b Relative expression (mean ± SEM, calculated from a standard curve) of selected miRNAs in paired blood plasma
and cell samples from six cows. All expression levels were normalised to cel-miR-39-3p
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Fig. 5 (See legend on next page.)
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enriched miRNAs across different bovine tissues re-
vealed miR-802, a previously unidentified bovine
miRNA, to be highly enriched in liver. The miRNA
database generated in this study provides a useful re-
source for future investigation of miRNA biology in
bovine and identification of additional potential bio-
markers of tissue function in livestock.
Additional files
Additional file 1: Sequencing miRNA analysis. Normalised miRNA
expression levels in bovine blood plasma and cell samples, and the
results of differential expression analysis between the two sample types.
(XLSX 47 kb)
Additional file 2: Validation of sequencing data. Validation of
sequencing results for selected miRNAs using RT-qPCR on an independ-
ent group of four animals. (TIFF 1669 kb)
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Fig. 5 MiRNA profiling across bovine tissues. Relative expression (mean ± SEM) of selected plasma-enriched miRNAs across 14 bovine tissues. a
MiRNAs reported to be tissue-enriched in humans. b MiRNAs not registered in humans. c Human miRNA homologues not identified previously
in bovine. RT-qPCR was run on 2–6 samples per tissue. Placenta = Day 70 of pregnancy; Placenta (T) = Term. All expression levels were normalised
to RNU6–2
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